{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:24:05Z","timestamp":1759040645520,"version":"3.44.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jad.2022.09.037","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T11:20:24Z","timestamp":1663932024000},"page":"610-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Electrical stimulus combined with venlafaxine and mirtazapine improves brain Ca2+ activity, pre-pulse inhibition, and immobility time in a model of major depressive disorder in schizophrenia"],"prefix":"10.1016","volume":"319","author":[{"given":"Chuanjun","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2022.09.037_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4088\/JCP.09m05258gre","article-title":"Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia","volume":"72","author":"Addington","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"22","key":"10.1016\/j.jad.2022.09.037_bb0010","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1523\/JNEUROSCI.2387-19.2020","article-title":"Venlafaxine stimulates an MMP-9-dependent increase in excitatory\/inhibitory balance in a stress model of depression","volume":"40","author":"Alaiyed","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2022.09.037_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172817","article-title":"The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior","volume":"187","author":"Alvarez Silva","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2022.09.037_bb0020","article-title":"Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia","volume":"3","author":"Barber","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2022.09.037_bb0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1192\/bjp.177.6.516","article-title":"Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression","volume":"177","author":"Birchwood","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00406-005-0588-4","article-title":"Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations","volume":"255","author":"Birchwood","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2022.09.037_bb0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.2044-8260.2012.02037.x","article-title":"A prospective study of PTSD following recovery from first episode psychosis: the threat from persecutors, voices, and patienthood","volume":"51","author":"Brunet","year":"2012","journal-title":"Brit. J. Clin. Psychol."},{"key":"10.1016\/j.jad.2022.09.037_bb0040","article-title":"The mouse forced swim test","volume":"e3638","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jad.2022.09.037_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.schres.2006.09.027","article-title":"The burden of depressive symptoms in the long-term treatment of patients with schizophrenia","volume":"90","author":"Conley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.09.037_bb0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.brs.2011.04.004","article-title":"Effects of repeated electroconvulsive shock on methamphetamine-induced behavioral abnormalities in mice","volume":"5","author":"Chao","year":"2012","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2022.09.037_bb0055","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2022.09.037_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/schbul\/sbaa153","article-title":"Comorbid major depressive disorder in schizophrenia: a systematic review and meta-analysis","volume":"47","author":"Etchecopar-Etchart","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2022.09.037_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.85","article-title":"Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse","volume":"7","author":"Feldcamp","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jad.2015.11.017","article-title":"Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set","volume":"191","author":"Fond","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.09.037_bb0080","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.2018.87","article-title":"Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort","volume":"213","author":"Fond","year":"2018","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2022.09.037_bb0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/nu12041024","article-title":"Microbiota-orientated treatments for major depression and schizophrenia","volume":"8;12","author":"Fond","year":"2020","journal-title":"Nutrients"},{"issue":"97","key":"10.1016\/j.jad.2022.09.037_bb0090","article-title":"Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia","volume":"8","author":"Fond","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0095","first-page":"11","article-title":"Clozapine: why is it so uniquely effective in the treatment of a range of neuropsychiatric disorders?","author":"Gammon","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jad.2022.09.037_bb0105","first-page":"175","article-title":"The pharmacologic treatment of schizophrenia-2021","volume":"325","author":"Goff","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2022.09.037_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/neu.2015.8","article-title":"Combined use of clozapine and ECT: a review","volume":"27","author":"Grover","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jad.2022.09.037_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/08039488.2021.1877349","article-title":"Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (non-CRS)","volume":"75","author":"Grover","year":"2021","journal-title":"Nord. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2022.09.037_bb0125","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.brs.2018.08.001","article-title":"Short- and long-term efficacy of electroconvulsive stimulation in animal models of depression: the essential role of neuronal survival","volume":"11","author":"Jonckheere","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2022.09.037_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0269881107065738","article-title":"Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness","volume":"21","author":"Hannan","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.09.037_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/YCT.0000000000000143","article-title":"Electroconvulsive therapy's mechanism of action: neuroendocrine hypotheses","volume":"30","author":"Haskett","year":"2014","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2022.09.037_bb0140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0145","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","volume":"5","author":"Hetrick","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.jad.2022.09.037_bb0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1017\/S1352465812001026","article-title":"Metacognitive therapy in treatment-resistant psychosis: a multiple-baseline study","volume":"42","author":"Hutton","year":"2014","journal-title":"Behav. Cogn. Psychother."},{"key":"10.1016\/j.jad.2022.09.037_bb0160","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.brs.2018.08.001","article-title":"Short- and long-term efficacy of electroconvulsive stimulation in animal models of depression: the essential role of neuronal survival","volume":"11","author":"Jonckheere","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2022.09.037_bb0165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm.4274","article-title":"Nicotine reverses hypofrontality in animal models of addiction and schizophrenia","volume":"23","author":"Koukouli","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jad.2022.09.037_bb0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/neu.2020.32","article-title":"Augmentation of clozapine with ECT: a retrospective case analysis","volume":"33","author":"Lally","year":"2021","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jad.2022.09.037_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","article-title":"Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials","volume":"287","author":"Li","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.09.037_bb0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fpsyg.2020.00080","article-title":"Effects of electroconvulsive therapy on depression and its potential mechanism","volume":"11","author":"Li","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2022.09.037_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2017.10.019","article-title":"Swimming exercise reverses CUMS-induced changes in depression-like behaviors and hippocampal plasticity-related proteins","volume":"227","author":"Liu","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.09.037_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2019.12.011","article-title":"Depressive symptoms during first episode psychosis and functional outcome: a systematic review and meta-analysis","volume":"218","author":"McGinty","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.09.037_bb0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/106002809502900410","article-title":"Venlafaxine: a structurally unique and novel antidepressant","volume":"29","author":"Morton","year":"1995","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.jad.2022.09.037_bb0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brs.2020.11.001","article-title":"Ryanodine receptors are involved in the improvement of depression-like behaviors through electroconvulsive shock in stressed mice","volume":"14","author":"Nakamura-Maruyama","year":"2021","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2022.09.037_bb0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2012.10.052","article-title":"Effects of single and repeated electroconvulsive stimulation on hippocampal cell proliferation and spontaneous behaviors in the rat","volume":"1491","author":"Nakamura","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2022.09.037_bb0225","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3389\/fphar.2018.01049","article-title":"Clozapine pharmacogenetic studies in schizophrenia: efficacy and agranulocytosis","volume":"9","author":"Numata","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2022.09.037_bb0230","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/med.21671","article-title":"New-generation, non-SSRI antidepressants: drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others","volume":"40","author":"Protti","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jad.2022.09.037_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108030","article-title":"Protective effects of mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: Relevance for myotonic dystrophy 1","volume":"170","author":"Ramon-Duaso","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2022.09.037_bb0240","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1177\/0269881110376696","article-title":"Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results","volume":"24","author":"Ruiz-Doblado","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.09.037_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.schres.2005.07.035","article-title":"Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials","volume":"80","author":"Rummel","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.09.037_bb0250","series-title":"StatPearls [Internet]","article-title":"Electroconvulsive therapy","author":"Salik","year":"2021"},{"key":"10.1016\/j.jad.2022.09.037_bb0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/YCO.0000000000000418","article-title":"Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature","volume":"31","author":"Sanghani","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0260","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.brs.2015.05.011","article-title":"Antidepressant-like effects of electroconvulsive seizures require adult neurogenesis in a neuroendocrine model of depression","volume":"8","author":"Schloesser","year":"2015","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2022.09.037_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108103","article-title":"MK-801 impairs working memory on the Trial-Unique Nonmatch-to-Location test in mice, but this is not exclusively mediated by NMDA receptors on PV+ interneurons or forebrain pyramidal cells","volume":"171","author":"Sokolenko","year":"2020","journal-title":"Neuropharmacology"},{"year":"2013","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis And Practical Applications 4th Edition, Kindle Edition","author":"Stahl","key":"10.1016\/j.jad.2022.09.037_bb0270"},{"issue":"5","key":"10.1016\/j.jad.2022.09.037_bb0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1192\/bjp.bp.114.155945","article-title":"NICE CG178 psychosis and schizophrenia in adults: treatment and management - an evidence-based guideline?","volume":"206","author":"Taylor","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0285","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.clinthera.2017.05.347","article-title":"Efficacy of venlafaxine in neuropathic pain: a narrative review of optimized treatment","volume":"39","author":"Trouvin","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2022.09.037_bb0290","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0447.2009.01506.x","article-title":"The evolution of depression and suicidality in first episode psychosis","volume":"122","author":"Upthegrove","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2022.09.037_bb0295","first-page":"1751","article-title":"Cultural and social influences of negative illness appraisals in first-episode psychosis","volume":"5","author":"Upthegrove","year":"2012","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.jad.2022.09.037_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.psychres.2014.03.023","article-title":"Depression in first episode psychosis: the role of subordination and shame","volume":"217","author":"Upthegrove","year":"2014","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.jad.2022.09.037_bb0310","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41386-020-00872-9","article-title":"Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia","volume":"46","author":"Valle-Le\u00f3n","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2022.09.037_bb0320","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/cn400121z","article-title":"Classics in chemical neuroscience: clozapine","volume":"4","author":"Wenthur","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jad.2022.09.037_bb0325","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0033291703007645","article-title":"Antidepressants for the treatment of depression in people with schizophrenia: a systematic review","volume":"33","author":"Whitehead","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2022.09.037_bb0330","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fnins.2020.00517","article-title":"Metformin enhances antidepressant\/antipsychotic combination therapy of schizophrenia with comorbid depression in a murine model","volume":"14","author":"Zhou","year":"2020","journal-title":"Front. Neurosci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722010424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722010424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:53:17Z","timestamp":1759031597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722010424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":56,"alternative-id":["S0165032722010424"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.09.037","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrical stimulus combined with venlafaxine and mirtazapine improves brain Ca2+ activity, pre-pulse inhibition, and immobility time in a model of major depressive disorder in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}